Parkinson's Disease Trial, By Invitation NCT07440563 Sponsor: Gazi University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, By Invitation

NCT07440563
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with Parkinson's disease by a neurologist using a specific set of recognised diagnostic guidelines called the United Kingdom Brain Bank criteria.
  • People who are 40 years of age or older.
  • People whose Parkinson's disease falls within a mild-to-moderate range of severity, as measured by a standard rating scale called the Modified Hoehn and Yahr Staging Scale (stages 1 to 3).
  • People who have been on a stable medication routine for their condition.
  • People who are able to turn around fully and walk 30 metres on their own, without help from another person or a mobility aid.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who score below 21 out of 30 on a standard memory and thinking assessment called the Montreal Cognitive Assessment (MoCA).
  • People who have vision or hearing problems that have not been corrected.
  • People who have additional conditions affecting the brain or nervous system (such as migraine), the bones or joints (such as osteoarthritis), or the heart and circulation (such as a previous heart attack, poorly controlled high blood pressure, or irregular heartbeat).
  • People who have a cardiac pacemaker.
  • People who have any metal implants located in the head or neck area.
  • People who have previously had deep brain stimulation surgery.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Gazi University
Registry
ClinicalTrials.gov
Start date
3 March 2026
Est. completion
23 March 2027

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Movement Disorders Society-Unified Parkinson's Disease Rating Scale; Postural Stability; Spatiotemporal Gait Parameters; Functional Walking Capacity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov